The Effect of Cytokine-Stimulation and Pharmacologic Intervention on PGE2 Production in Primary Human Conjunctival and Corneal Cells.
Eisuke ShimizuHiroyuki YazuYoshiyuki SatakeKazumi FukagawaNaohiko AketaDogru MuratNaoko OkadaHiroshi FujishimaPublished in: Ocular immunology and inflammation (2019)
We studied the production of PGE2 by human conjunctival and corneal cells in response to inflammation, and reduction of inflammation with non-steroidal anti-inflammatory drugs. Primary cultures of human conjunctival epithelial cells, fibroblasts, corneal epithelial cells, and keratocytes were incubated with IL-4 and TNF-α. PGE2 and COX-2 levels were analyzed. Effects of anti-inflammatory and anti-immune drugs on PGE2 production were also investigated. IL-4 and TNF-α induced the generation of PGE2 and COX-2 in conjunctival and corneal cells. Epithelial PGE2 production was significantly lower than in keratocytes and fibroblasts, which was down-regulated by aspirin. IL-4 and TNF-α enhanced the inflammatory response via prostaglandin production which contributed to ocular surface inflammation. Prostaglandin production was higher in stromal cells than epithelial cells. These results suggest that the epithelial barrier disruption may contribute to ocular allergic inflammation by the PGE2 production from stromal cells. Moreover, NSAIDs were effective in suppressing PGE2 production in our experiment.
Keyphrases
- induced apoptosis
- anti inflammatory drugs
- oxidative stress
- endothelial cells
- inflammatory response
- rheumatoid arthritis
- optical coherence tomography
- cell cycle arrest
- randomized controlled trial
- low dose
- signaling pathway
- type diabetes
- cardiovascular disease
- coronary artery disease
- high glucose
- cardiovascular events
- induced pluripotent stem cells
- diabetic rats
- cell proliferation
- pluripotent stem cells
- drug induced
- toll like receptor
- lps induced
- single molecule
- atopic dermatitis